Cardiac Remote Patient Monitoring Devices Market Size & Share Analysis - Industry Research Report

The remote cardiac monitoring is a method by which the data from patients implanted rhythm management system can be transferred directly to the physician’s office. The physician treating a particular individual gets the information by using the integrated aerial in which the implant automatically sends medical and technical information from the heart. This gives access to the physician to monitor the accurate and current clinical information even if the patient is not in the hospital.

The remote patient monitoring device, monitors and captures medical and other health related data from the patients and transfers the information to healthcare suppliers for assessment as per recommended.

The cardiac remote patient monitoring device is estimated to be valued at US$ 396 Mn in 2021 and is expected to register a CAGR of 7.9% and reach US$ 680 Mn by 2028.

Figure 1. Global Cardiac Remote Patient Monitoring Device Market (US$ Mn), By Application, 2021

CARDIAC REMOTE PATIENT MONITORING DEVICES MARKET

To learn more about this report, request sample copy

Figure 1.1 Global Cardiac Remote Patient Monitoring Device Market (US$ Mn), By Application, 2028

CARDIAC REMOTE PATIENT MONITORING DEVICES MARKET

To learn more about this report, request sample copy

The increasing product launches and approvals are expected to drive the market growth over the forecast period.

For instance, in September 2021, VitalConnect Inc., head in remote and in hospital wearable biosensor technology, had introduced its latest version of VistaCenter for cardiac and remote patient monitoring. This latest version helps in making the patient management easier and less time-intensive for physicians.

Cardiac Remote Patient Monitoring Device Market Report Coverage

Report Coverage	Details
Base Year:	2020	Market Size in 2021:	US$ 396 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2021 to 2028
Forecast Period 2021 to 2028 CAGR:	7.9%	2028 Value Projection:	US$ 680 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Applications: Cardiac Arrhythmia, Ischemic Diseases, Hypertension By End Users: Application: Hospitals, Cardiac Clinics, Ambulatory Surgery Centers
Companies covered:	A & D Medical, BIOTRONIK SE & Co. KG, Boston Scientific, GE Healthcare, Honeywell, Medtronic plc, Nihon Khoden, Philips Healthcare, Spacelabs Healthcare, Abbott Laboratories, St. Jude Medical, VitalConnect Inc., OSYPKA, MeTrax GmbH, and Lepu Medical Technology
Growth Drivers:	Increasing applications of cardiac monitors Investments in R&D of heart diseases detection
Restraints & Challenges:	Risk of infection due to implantable monitoring devices Lack of skilled personnel to operate and monitor devices

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Global Cardiac Remote Patient Monitoring Device Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China.

In 83 participating centers, the use of remote monitoring has been increased due to COVID 19 pandemic. The rate of participating centers located in other regions was similar to the regions in which the use of remote monitoring was higher due to COVID-19 cases. The number of cardiovascular implantable electronic device patients followed up by remote monitoring increased from 15% to 30% in 2021. The difference in the centers situated for higher incidence of COVID-19 cases was not found as compared to the other centers. About 33% of the participating centers reported no increase in utilization of remote monitoring as a result of COVID-19 pandemic.

Organizational issues and personnel shortage, lack of perception of the need, were the most frequent reasons for less increase in number of patients followed up by remote monitoring.

Global Cardiac Remote Patient Monitoring Device Market - Restraint

As per stated in AHA Journals, complications can be seen frequently as the indications of CIEDs (Cardiovascular implantable electronic devices) increases. The general trend for increase in CIED infection is been noticed, because with the associated comorbidities people live longer.

The device infection rates ranges from 2% to 8%, as per the several observational studies. Moreover, the implantable cardioverter defibrillators have the higher rate of infection.

Key Players

Major players operating in the global cardiac remote patient monitoring device market include A & D Medical, BIOTRONIK SE & Co. KG, Boston Scientific, GE Healthcare, Honeywell, Medtronic plc, Nihon Khoden, Philips Healthcare, Spacelabs Healthcare, Abbott Laboratories, St. Jude Medical, VitalConnect Inc., OSYPKA, Lepu Medical Technology, and MeTrax GmbH.

About Author

Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.

Missing comfort of reading report in your local language? Find your preferred language :

Transform your Strategy with Exclusive Trending Reports :

Micro Guide Catheters Market

Bioabsorbable Stents Market

Cardiac Ablation Catheters Market

Vaccines Delivery Devices Market

Wearable Sensors Market

3d Printed Medical Implants Market

Frequently Asked Questions

The global Cardiac Remote Patient Monitoring Devices Market size was valued at USD 396 million in 2021 and is expected to reach USD 680 million in 2028.

The Cardiac Remote Patient Monitoring Devices Market is estimated to be valued at US$ 396 million in 2021 and is expected to exhibit a CAGR of 7.9% over the forecast period (2021-2028).

The increasing applications of cardiac monitors, investments in R&D of heart disease detection are the major factors which are expected to drive the market growth over the forecast period.

Cardiac monitors is expected to hold major market share. Cardiac monitoring allows for continual observation of several patients with heart disorders, with the most common uses in emergency rooms and critical care areas.

Major factors hampering growth of the market include risk of infection due to implantable monitoring devices, lack of skilled personnel to operate and monitor devices.

Major players operating in the market include A & D Medical, BIOTRONIK SE & Co. KG, Boston Scientific, GE Healthcare, Honeywell, Medtronic plc, Nihon Khoden, Philips Healthcare, Spacelabs Healthcare, Abbott Laboratories, St. Jude Medical, VitalConnect Inc., OSYPKA, MeTrax GmbH, and Lepu Medical Technology.